APP Pharmaceuticals Recalls Cyanocobalamin Injections Due to Sterility Risk
APP Pharmaceuticals recalls specific lots of Cyanocobalamin Injection USP due to potential glass particles and lack of sterility assurance.
Stop using this now
Lack of Assurance of Sterility: Glass vials may have finish fractures and glass particles.
Contact the company
What happened, in plain English
APP Pharmaceuticals, LLC is recalling Cyanocobalamin Injection, USP (1000 mcg/mL) because the glass vials may have finish fractures that could introduce glass particles. This defect raises concerns about the assurance of sterility for the medication. The recall affects a nationwide distribution including Puerto Rico. Read more at govinfonow.com/recall/48528-fresenius-kabi-usa-llc-recalls-cyanocobalamin-injection-usp-1000-mcg.
Source Summary by GovInfoNow · govinfonow.com/recall/48528-fresenius-kabi-usa-llc-recalls-cyanocobalamin-injection-usp-1000-mcg · Updated October 13, 2026 · FDA enforcement record: FDA #D-0297-2015
Cite this page
“APP Pharmaceuticals Recalls Cyanocobalamin Injections Due to Sterility Risk.” GovInfoNow, updated October 13, 2026. https://govinfonow.com/recall/48528-fresenius-kabi-usa-llc-recalls-cyanocobalamin-injection-usp-1000-mcg. Based on FDA recall #D-0297-2015 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0297-2015%22&limit=1).
Why it’s dangerous
The glass vials may contain finish fractures, which can lead to glass particles entering the injection. Additionally, these defects compromise the assurance of sterility, potentially allowing bacteria or other contaminants into the medication, posing a serious health risk if injected.
Who’s affected
Patients who have received or possess Cyanocobalamin Injection, USP from the specific lot listed below are at risk. Healthcare providers administering this drug must also be aware of the potential contamination.
How to tell if you have this one
Check for Cyanocobalamin Injection, USP, 1000 mcg/mL in Multiple Dose 2 mL Vials. Look for NDC: 63323-044-01 and Lot number 6003853 with an expiration date of 04/2014.
- Brand
APP Pharmaceuticals- Category
Drug
All 3 products in this recall
FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.
- Classification
Class II- Status
Terminated- Distribution
U.S. Nationwide Including Puerto Rico
| Recall number | Product, codes & lots | Quantity | NDC |
|---|---|---|---|
| D-0295-2015 | MIDAZOLAM HYDROCHLORIDE INJECTION, 5 mg/1 mL, C-IV, For IM or IV Use, 2 mL Vials, Rx only. APP Pharmaceuticals, LLC. Schaumburg, IL 60173. NDC: 63323-412-25.; Lot 6003827, Exp. Date 04/2015 | 101,200 Vials | 63323-411-22, 63323-411-27, 63323-411-15, 63323-411-12, 63323-411-18, 63323-411-25, 63323-411-13, 63323-411-10, 63323-412-18, 63323-412-25, 63323-412-03, 63323-412-02, 63323-412-06, 63323-412-05, 63323-412-13, 63323-412-10 |
| D-0296-2015 | ONDANSETRON INJECTION, USP, 4 mg/ 2 mL (2 mg/mL), For IM or IV Use, Single Dose 2 mL Vials, Rx only. APP Pharmaceuticals, LLC, Schaumburg, IL 60173. NDC: 63323-373-02; Lot 6003930, exp. date 04/2014 | 184,550 Vials | 63323-373-00, 63323-373-02, 63323-374-20 |
| D-0297-2015 | CYANOCOBALAMIN INJECTION, USP, 1000 mcg/mL, For IM or IV Use, Multiple Dose 2 mL Vials, Rx only. APP Pharmaceuticals, LLC, Schaumburg, IL 60173. NDC: 63323-044-01.; Lot 6003853, exp. date 04/2014 | 240,550 Vials | 63323-044-00, 63323-044-01 |
What to do — step by step
Stop Using the Product
Do not use any vials matching the recalled lot number due to sterility and glass particle risks.
Contact Healthcare Provider
Consult your doctor or pharmacist immediately regarding the status of this medication and potential replacement options.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “U.S. Nationwide Including Puerto Rico” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 2.2 years after the firm started it.
- Firm started the recall
- FDA classified it Class II
- FDA terminated the recall
- Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
Questions people ask
What is the NDC for the recalled product?
The National Drug Code (NDC) is 63323-044-01.
Similar recalls
Other APP Pharmaceuticals recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0297-2015 (September 27, 2012) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0297-2015 to see it in context.
- Plain-language summary written by qwen3.6:35b-a3b on October 13, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.